Fintel reports that on July 25, 2025, William Blair downgraded their outlook for Ameriprise Financial (NYSE:AMP) from ...

Eli Lilly and Novo Nordisk are currently the only drugmakers with FDA approved weight-loss medicines on the U.S. market.

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

Palantir Technologies Inc. (NASDAQ: PLTR) is one of the best 52-week high stocks to buy now. On July 21, the stock was a big ...

Palo Alto Networks, Inc. (NASDAQ:PANW) is one of the best long term low volatility stocks to buy now. On July 16, William ...

The European Union’s health regulatory agency did not endorse approving Elevidys for ambulatory patients with Duchenne ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

He was preceded in death by sons William Blair III and Jordan Blair. Advertisement “He was a Renaissance man,” said Gregory Jordan, a nephew.

The William Blair venture that utilizes InvestCloud's cloud-based technology was created to give advisors access to a suite of proprietary software aimed at streamlining day-to-day operations and ...